A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth
about
Screening of a specific peptide binding to VPAC1 receptor from a phage display peptide libraryVIP blockade leads to microcephaly in mice via disruption of Mcph1-Chk1 signalingHuman renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone.Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mousePeptides with anticancer use or potential.Hierridin B Isolated from a Marine Cyanobacterium Alters VDAC1, Mitochondrial Activity, and Cell Cycle Genes on HT-29 Colon Adenocarcinoma Cells.Neuronally released vasoactive intestinal polypeptide alters atrial electrophysiological properties and may promote atrial fibrillation.Vasoactive intestinal peptide inhibits human small-cell lung cancer proliferation in vitro and in vivo.Vasoactive intestinal peptide-camptothecin conjugates inhibit the proliferation of breast cancer cells.Label-free optical biosensor: a tool for G protein-coupled receptors pharmacology profiling and inverse agonists identification.Administration of a vasoactive intestinal peptide antagonist enhances the autologous anti-leukemia T cell response in murine models of acute leukemia.Molecular imaging probes derived from natural peptides.Promotional effects of vasoactive intestinal peptide on the development of rodent Hertwig's epithelial root sheath.Pituitary adenylate cyclase-activating polypeptide causes increased tyrosine phosphorylation of focal adhesion kinase and paxillin.CD10/NEP in non-small cell lung carcinomas. Relationship to cellular proliferation.Neuropeptide regulation of mitosis.A lipophilic vasoactive intestinal peptide analog enhances the antiproliferative effect of chemotherapeutic agents on cancer cell lines.VIP and the potent analog, stearyl-Nle(17)-VIP, induce proliferation of keratinocytes.Lipoxygenase inhibitors prevent lung carcinogenesis and inhibit non-small cell lung cancer growth.Identity of neurotrophic molecules released from astroglia by vasoactive intestinal peptide.Characterization of the rat vasoactive intestinal polypeptide receptor gene 5' region.Inhibition of vasoactive intestinal polypeptide (VIP) induces resistance to dextran sodium sulfate (DSS)-induced colitis in micePACAP(6-38) is a PACAP receptor antagonist for breast cancer cells.Modulation of Immune Checkpoints and Graft-versus-Leukemia in Allogeneic Transplants by Antagonizing Vasoactive Intestinal Peptide Signaling.Thymosin alpha1 as a chemopreventive agent in lung and breast cancer.VPAC1 overexpression is associated with poor differentiation in colon cancer.Neuropeptide G Protein-Coupled Receptors as Oncotargets.
P2860
Q28485298-B681F836-1BDC-41BF-9788-8B47F56E2914Q28513601-FD29CCC6-6257-4DA9-A9F9-437882F5E38DQ30454262-DE7442AE-FC40-429B-AE42-AD45433A8FA6Q34158279-4C8DCBD0-B6E3-4CF7-B327-9D219AE7477DQ35167010-5E265F16-011E-4FB9-9904-8DA64FA0A875Q36121864-2CE0830E-2488-44B0-8EFC-78F500E73555Q36384591-194B5C4C-54D7-4048-9004-AC604AD33E44Q36734495-2132231F-57D9-4D7E-BDD0-B1FB52CA0689Q37342513-231E6D2C-D233-41AC-BE99-C083E9A53BDCQ37548454-5BBA1BA7-C61D-43B3-9E72-745880AFB18CQ38714704-0FA97AA6-D34F-4A46-86A7-29BA936907A5Q38748846-1C8BB685-0AA0-440D-AD67-578A5BC68CF0Q39290362-9274A1DD-12A0-4E54-9A4B-9DD1A31E979BQ39478560-BA5B1895-E849-45E6-B669-A7704A40A3D4Q40337525-40BB4AED-D071-4D36-96AB-F7610743D3D1Q40577751-E123A6A1-EAD4-43DC-A995-30EED7740E27Q40775461-85D4E665-9B27-46DA-926D-1A3C97D9F127Q40873269-9F6C490E-68A3-4F0A-AC5E-3B9675DDE8CCQ41026596-5BB8DACB-7FA7-467D-A80D-E1E599C51FB7Q41478941-B9F49D9D-4C14-48DB-B4A9-0F37E92C4559Q42160566-16AC85C6-A5E7-439E-B5EF-5102ABA4D6D5Q42754007-1B2D2717-2300-400A-BDD3-94263BA767FDQ42808312-A701B08F-490B-44CC-99BB-27E6A51A656DQ51450182-7BDFD606-A39B-4A49-81C6-CBDD574DD298Q51750277-F404C0C5-761C-4B87-97AA-F29F3CEF36B3Q54364555-4AE8E122-9666-4D26-86A1-2025DA3362BFQ55709770-74730983-C38F-4007-A2DA-61569E327843
P2860
A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth
description
1993 nî lūn-bûn
@nan
1993 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth
@ast
A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth
@en
A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth
@en-gb
A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth
@nl
type
label
A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth
@ast
A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth
@en
A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth
@en-gb
A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth
@nl
prefLabel
A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth
@ast
A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth
@en
A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth
@en-gb
A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth
@nl
P2093
P2860
P921
P3181
P356
P1476
A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth
@en
P2093
A Davidson
D E Brenneman
P2860
P304
P3181
P356
10.1073/PNAS.90.10.4345
P407
P577
1993-05-15T00:00:00Z